A runner's high depends on cannabinoid receptors in mice

Proceedings of the National Academy of Sciences of the United States of America

Volumn 112, Issue 42, 2015, Pages 13105-13108

  Fuss, Johannes ^a,b   Steinle, Jörg ^a   Bindila, Laura ^c   Auer, Matthias K ^d   Kirchherr, Hartmut ^e   Lutz, Beat ^c   Gass, Peter ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^d MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^e Medizinisches Labor Bremen   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 4 AMINOBUTYRIC ACID RECEPTOR; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; ENDOCANNABINOID; N OLEOYLETHANOLAMINE; NALOXONE; OPIATE RECEPTOR; PALMIDROL;

ANALGESIA; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR ASSESSMENT; BEHAVIOR CONTROL; BIOMECHANICS; CONTROLLED STUDY; ENZYME ACTIVATION; EUPHORIA; EXERCISE; FOREBRAIN; GABAERGIC SYSTEM; GENETIC ANALYSIS; MALE; MOLECULAR GENETICS; MOUSE; NERVE CELL; NOCICEPTION; NONHUMAN; PAIN ASSESSMENT; PRIORITY JOURNAL; RUNNING; SEDATION; TRANQUILIZING ACTIVITY; ANIMAL; C57BL MOUSE; PHYSIOLOGY;

ANIMALS; BEHAVIOR, ANIMAL; MALE; MICE; MICE, INBRED C57BL; PHYSICAL CONDITIONING, ANIMAL; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2; RUNNING;

EID: 84944707058     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1514996112     Document Type: Article

References (20)

1. Boecker H, et al. (2008) The runner's high: Opioidergic mechanisms in the human brain. Cereb Cortex 18(11):2523-2531.
2. Raichlen DA, Foster AD, Gerdeman GL, Seillier A, Giuffrida A (2012) Wired to run: Exercise-induced endocannabinoid signaling in humans and cursorial mammals with implications for the 'runner's high'. J Exp Biol 215(Pt 8):1331-1336.
3. Fuss J, Gass P (2010) Endocannabinoids and voluntary activity in mice: Runner's high and long-Term consequences in emotional behaviors. Exp Neurol 224(1):103-105.
4. Carr DB, et al. (1981) Physical conditioning facilitates the exercise-induced secretion of beta-endorphin and beta-lipotropin in women. N Engl J Med 305(10):560-563.
5. Sparling PB, Giuffrida A, Piomelli D, Rosskopf L, Dietrich A (2003) Exercise activates the endocannabinoid system. Neuroreport 14(17):2209-2211.
6. Hill MN, et al. (2010) Endogenous cannabinoid signaling is required for voluntary exercise-induced enhancement of progenitor cell proliferation in the hippocampus. Hippocampus 20(4):513-523.
7. Galdino G, et al. (2014) The endocannabinoid system mediates aerobic exerciseinduced antinociception in rats. Neuropharmacology 77:313-324.
8. Dubreucq S, et al. (2013) Ventral tegmental area cannabinoid type-1 receptors control voluntary exercise performance. Biol Psychiatry 73(9):895-903.
9. van Praag H, Christie BR, Sejnowski TJ, Gage FH (1999) Running enhances neurogenesis, learning, and long-Term potentiation in mice. Proc Natl Acad Sci USA 96(23): 13427-13431.
10. van Praag H, Kempermann G, Gage FH (1999) Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus. Nat Neurosci 2(3):266-270.
11. Snyder JS, Soumier A, Brewer M, Pickel J, Cameron HA (2011) Adult hippocampal neurogenesis buffers stress responses and depressive behaviour. Nature 476(7361):458-461.
12. Massa F, et al. (2010) Alterations in the hippocampal endocannabinoid system in dietinduced obese mice. J Neurosci 30(18):6273-6281.
13. Monory K, et al. (2006) The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51(4):455-466.
14. Fuss J, et al. (2013) Hippocampal serotonin-1A receptor function in a mouse model of anxiety induced by long-Term voluntary wheel running. Synapse 67(10):648-655.
15. Fuss J, et al. (2010) Voluntary exercise induces anxiety-like behavior in adult C57BL/6J mice correlating with hippocampal neurogenesis. Hippocampus 20(3):364-376.
16. Cluny NL, et al. (2010) A novel peripherally restricted cannabinoid receptor antagonist, AM6545, reduces food intake and body weight, but does not cause malaise, in rodents. Br J Pharmacol 161(3):629-642.
17. Gatley SJ, Gifford AN, Volkow ND, Lan R, Makriyannis A (1996) 123I-labeled AM251: A radioiodinated ligand which binds in vivo to mouse brain cannabinoid CB1 receptors. Eur J Pharmacol 307(3):331-338.
18. McLaughlin PJ, et al. (2003) The cannabinoid CB1 antagonists SR 141716A and AM 251 suppress food intake and food-reinforced behavior in a variety of tasks in rats. Behav Pharmacol 14(8):583-588.
19. Lomazzo E, et al. (2015) Therapeutic potential of inhibitors of endocannabinoid degradation for the treatment of stress-related hyperalgesia in an animal model of chronic pain. Neuropsychopharmacology 40(2):488-501.
20. Glass PS, Jhaveri RM, Smith LR (1994) Comparison of potency and duration of action of nalmefene and naloxone. Anesth Analg 78(3):536-541.